Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02350854
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
|---|---|---|---|---|---|
| Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
UA1 | N-(TERT-BUTOXYCARBONYL)-L-TYROSYL- N-METHYL-4-(SULFOAMINO)-L-PHENYLALANINAMIDE | A | 2I4H | 0.73 |  |
| UA1 | N-(TERT-BUTOXYCARBONYL)-L-TYROSYL- N-METHYL-4-(SULFOAMINO)-L-PHENYLALANINAMIDE | A | 2I4G | 0.73 | |
393 | (5-CHLORO-2-{[(3-NITROBENZYL)AMINO]CARBONYL}PHENOXY)ACETIC ACID | A | 2PDU | 0.75 | |
| 393 | (5-CHLORO-2-{[(3-NITROBENZYL)AMINO]CARBONYL}PHENOXY)ACETIC ACID | A | 2PDC | 0.75 | |
| 393 | (5-CHLORO-2-{[(3-NITROBENZYL)AMINO]CARBONYL}PHENOXY)ACETIC ACID | A | 2PDP | 0.75 | |
| 393 | (5-CHLORO-2-{[(3-NITROBENZYL)AMINO]CARBONYL}PHENOXY)ACETIC ACID | A | 2PZN | 0.75 | |
| 393 | (5-CHLORO-2-{[(3-NITROBENZYL)AMINO]CARBONYL}PHENOXY)ACETIC ACID | A | 2PDJ | 0.75 | |
| 393 | (5-CHLORO-2-{[(3-NITROBENZYL)AMINO]CARBONYL}PHENOXY)ACETIC ACID | A | 2IKJ | 0.75 | |
194 | 4-{2-[(3-NITROBENZOYL)AMINO]PHENOXY}PHTHALIC ACID | A | 1Z6P | 0.73 | |
ST1 | 4-(ACETYLAMINO)-3-HYDROXY-5-NITROBENZOIC ACID | A,B | 1IVD | 0.77 | |
| ST1 | 4-(ACETYLAMINO)-3-HYDROXY-5-NITROBENZOIC ACID | A | 1IVB | 0.77 | |
IFB | N-[(2',4'-DIFLUORO-4-HYDROXY-5- IODOBIPHENYL-3-YL)CARBONYL]-BETA- ALANINE | A,B | 3FCB | 0.73 | |
NPA | 2-(4-HYDROXY-3-NITROPHENYL)ACETIC ACID | H | 1NGP | 0.72 | |
ECA | N,N',N''-[BENZENE-1,3,5-TRIYLTRIS(METHYLENE)]TRIS(2,3- DIHYDROXYBENZAMIDE) | A,B | 2CHU | 0.73 | |
HNA | 1,8-DI-HYDROXY-4-NITRO-ANTHRAQUINONE | A | 1M2P | 0.71 | |
GN8 | (Z)-3-BENZYL-5-(2-HYDROXY-3-NITROBENZYLIDENE)- 2-THIOXOTHIAZOLIDIN-4-ONE | A,B,C,D,E,F | 2P6F | 0.79 | |
ANY | 2-METHYL-BUTYRIC ACID 3-(3-FORMYLAMINO- 2-HYDROXY-BENZOYLAMINO)-8-HEPTYL- 2,6-DIMETHYL-4,9-DIOXO-[1,5]DIOXONAN- 7-YL ESTER | A,C,D,E,N,P, Q,R | 3H1I | 0.76 | |
| ANY | 2-METHYL-BUTYRIC ACID 3-(3-FORMYLAMINO- 2-HYDROXY-BENZOYLAMINO)-8-HEPTYL- 2,6-DIMETHYL-4,9-DIOXO-[1,5]DIOXONAN- 7-YL ESTER | A,B,C,D,E,F, G,O,P,Q,R,S,T | 1PPJ | 0.76 | |
NIY | META-NITRO-TYROSINE | A | 2ADP | 0.77 | |
| NIY | META-NITRO-TYROSINE | A | 3DIV | 0.77 | |
| NIY | META-NITRO-TYROSINE | A | 2H5U | 0.77 | |
| NIY | META-NITRO-TYROSINE | A | 1K4Q | 0.77 | |
| NIY | META-NITRO-TYROSINE | B,G,O,Y | 1SDA | 0.77 | |
LVS | 4-IODO-3-NITROPHENYL ACETYL-LEUCINYL- LEUCINYL-LEUCINYL-VINYLSULFONE | A,B,C,D,E,F, G,H,I,J,K,L, M,N,O,P,Q,R, S,T,U,V,W,X | 1KYI | 0.78 | |
| LVS | 4-IODO-3-NITROPHENYL ACETYL-LEUCINYL- LEUCINYL-LEUCINYL-VINYLSULFONE | A,B,C,G,H,I, L,M,N | 1OFI | 0.78 | |
LJ5 | N-(3,5-dibromo-4-hydroxyphenyl)benzamide | A,B | 3CN4 | 0.71 | |
P28 | 3',5'-DINITRO-N-ACETYL-L-THYRONINE | A,B | 2ROY | 0.75 | |
BIE | (3,4-DIHYDROXY-2-NITROPHENYL)(PHENYL)METHANONE | A,B | 2CL5 | 0.7 | |
AMY | ANTIMYCIN | C,D,E | 3BCC | 0.76 | |
BJH | 1(R)-1-ACETAMIDO-2-(3-CARBOXY-2- HYDROXYPHENYL)ETHYL BORONIC ACID | A | 1ERQ | 0.7 | |
AZY | 3-AZIDO-L-TYROSINE | A | 2YXN | 0.71 | |
SHA | SALICYLHYDROXAMIC ACID | X | 1V0H | 0.7 | |
| SHA | SALICYLHYDROXAMIC ACID | A | 2QPK | 0.7 | |
| SHA | SALICYLHYDROXAMIC ACID | A | 3FNL | 0.7 | |
| SHA | SALICYLHYDROXAMIC ACID | A | 3GCJ | 0.7 | |
| SHA | SALICYLHYDROXAMIC ACID | A | 1CK6 | 0.7 | |
ANT | ANTHRAMYCIN | A | 274D | 0.72 | |
MNX | 1,8-DI-HYDROXY-4-NITRO-XANTHEN- 9-ONE | A | 1M2Q | 0.7 | |
ANJ | (2R,3S,6S,7R,8R)-3-{[3-(FORMYLAMINO)- 2-HYDROXYBENZOYL]AMINO}-8-HEXYL- 2,6-DIMETHYL-4,9-DIOXO-1,5-DIOXONAN- 7-YL (2S)-2-METHYLBUTANOATE | A,B,C,D,E,F, G,H,I,J,K,L | 2QJP | 0.76 | |
| ANJ | (2R,3S,6S,7R,8R)-3-{[3-(FORMYLAMINO)- 2-HYDROXYBENZOYL]AMINO}-8-HEXYL- 2,6-DIMETHYL-4,9-DIOXO-1,5-DIOXONAN- 7-YL (2S)-2-METHYLBUTANOATE | A,B,C,D,E,F, G,H,I,J,K,L, M,N,O,P,Q,R | 2QJK | 0.76 | |
ATC | 9-(N,N-DIMETHYLGLYCYLAMIDO)-6-DEOXY- 6-DEMETHYL-TETRACYCLINE | A | 1ORK | 0.73 | |
TY2 | 3-AMINO-L-TYROSINE | A,B | 2VH3 | 0.71 | |
EB4 | N,N',N''-[(3S,7S,11S)-2,6,10-trioxo- 1,5,9-trioxacyclododecane-3,7,11- triyl]tris(2,3-dihydroxybenzamide) | A,B,C | 3CMP | 0.71 | |
135 | N-(4-CARBAMIMIDOYL-PHENYL)-2-HYDROXY- BENZAMIDE | B | 1GJA | 0.76 | |
IFA | A,B | 3FC8 | 0.72 | | |
BFS | N-[1-(4-BROMOPHENYL)ETHYL]-5-FLUORO SALICYLAMIDE | A | 1STD | 0.72 | |
| BFS | N-[1-(4-BROMOPHENYL)ETHYL]-5-FLUORO SALICYLAMIDE | A,B,C | 4STD | 0.72 | |
ST6 | 4-(ACETYLAMINO)-3-[(AMINOACETYL)AMINO]BENZOIC ACID | A,B | 1INH | 0.71 | |
ST2 | 4-(ACETYLAMINO)-5-AMINO-3-HYDROXYBENZOIC ACID | A,B | 1IVC | 0.73 | |
NPC | 4-HYDROXY-3-NITROPHENYLACETYL-EPSILON- AMINOCAPROIC ACID ANION | H,I,J | 1A6V | 0.82 | |
DBS | 2-(2,3-DIHYDROXY-BENZOYLAMINO)- 3-HYDROXY-PROPIONIC ACID | A,B,C | 1L6M | 0.7 | |
| DBS | 2-(2,3-DIHYDROXY-BENZOYLAMINO)- 3-HYDROXY-PROPIONIC ACID | A,B,C | 3CBC | 0.7 | |
| DBS | 2-(2,3-DIHYDROXY-BENZOYLAMINO)- 3-HYDROXY-PROPIONIC ACID | A,B,C | 3BY0 | 0.7 | |
C00 | 2-(4-hydroxybiphenyl-3-yl)-4-methyl- 1H-isoindole-1,3(2H)-dione | A | 3BYX | 0.7 | |
| C00 | 2-(4-hydroxybiphenyl-3-yl)-4-methyl- 1H-isoindole-1,3(2H)-dione | A | 3BZ0 | 0.7 | |
R36 | 4-AMINO-N-{4-[2-(2,6-DIMETHYL-PHENOXY)- ACETYLAMINO]-3-HYDROXY-1-ISOBUTYL- 5-PHENYL-PENTYL}-BENZAMIDE | A | 1LEE | 0.71 | |
NIP | 4-HYDROXY-5-IODO-3-NITROPHENYLACETYL- EPSILON-AMINOCAPROIC ACID ANION | H | 1A6W | 0.8 | |
CLC | N-ACETYL-P-NITROPHENYLSERINOL | A | 1GRR | 0.7 | |
SCL | ACETIC ACID SALICYLOYL-AMINO-ESTER | A | 1EBV | 0.7 | |
BIA | 1-(3,4,DIHYDROXY-5-NITROPHENYL)- 3-{4-[3-(TRIFLUOROMETHYL) PHENYL] PIPERAZIN- 1-YL}PROPAN-1-ONE | A | 1H1D | 0.75 | |
PNF | 6-{4-[HYDROXY-(4-NITRO-PHENOXY)- PHOSPHORYL]-BUTYRYLAMINO}-HEXANOIC ACID | L | 1YEJ | 0.7 | |
MIX | 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)- 9,10-ANTHRACENEDIONE | A,B,C,D | 2FUM | 0.72 | |
R69 | N-[4-({4-[5-(DIMETHYLAMINO)-2-HYDROXYBENZOYL]BENZOYL}AMINO)AZEPAN- 3-YL]ISONICOTINAMIDE | A | 1XH4 | 0.71 | |
| R69 | N-[4-({4-[5-(DIMETHYLAMINO)-2-HYDROXYBENZOYL]BENZOYL}AMINO)AZEPAN- 3-YL]ISONICOTINAMIDE | A | 1XH9 | 0.71 | |